#ASCO26: Kelonia Therapeutics delivers an impressive in vivo CAR-T update

Inside #ASCO26 (Karen Weintraub for Endpoints News) June 1, 2026 10:29 AM EDTUpdated 12:10 PM R&D Kelo­nia Ther­a­peu­tics de­liv­ers im­pres­sive in vi­vo CAR-T up­date Lei Lei Wu News Reporter CHICA­GO — Eli Lil­ly in April signed an up to $7 bil­lion deal to buy Kelo­nia Ther­a­peu­tics, and now we know why. All 18 mul­ti­ple … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER